Goldman Sachs Group Inc Pfizer Inc Put Options Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Put Options

19 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $387,800 - $439,460	-14,000 Reduced 2.65%	514,800 $14.9 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $310,698 - $364,080	12,300 Added 2.38%	528,800 $14.8 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $5.09 Million - $5.85 Million	-196,700 Reduced 27.58%	516,500 $14.3 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $27.8 Million - $36.1 Million	-1,065,000 Reduced 59.89%	713,200 $20.5 Million
Q3 2023 May 14, 2024	BUY	$32.09 - $37.51 $34.2 Million - $39.9 Million	1,065,000 Added 149.33%	1,778,200 $59 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $35.2 Million - $41.1 Million	1,095,500 Added 160.47%	1,778,200 $59 Million
Q2 2023 May 14, 2024	SELL	$36.12 - $41.79 $650,160 - $752,220	-18,000 Reduced 2.57%	682,700 $25 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $650,160 - $752,220	-18,000 Reduced 2.57%	682,700 $25 Million
Q1 2023 May 14, 2024	SELL	$39.39 - $51.28 $26.3 Million - $34.3 Million	-668,000 Reduced 48.81%	700,700 $28.6 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $26.3 Million - $34.3 Million	-668,000 Reduced 48.81%	700,700 $28.6 Million
Q4 2022 May 14, 2024	SELL	$41.75 - $54.5 $4.7 Million - $6.14 Million	-112,600 Reduced 7.6%	1,368,700 $70.2 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $4.7 Million - $6.14 Million	-112,600 Reduced 7.6%	1,368,700 $70.2 Million
Q3 2022 May 14, 2024	SELL	$43.76 - $53.42 $3.1 Million - $3.78 Million	-70,800 Reduced 4.56%	1,481,300 $64.8 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $3.1 Million - $3.78 Million	-70,800 Reduced 4.56%	1,481,300 $64.8 Million
Q2 2022 May 14, 2024	BUY	$46.53 - $55.17 $39 Million - $46.3 Million	838,900 Added 117.62%	1,552,100 $81.4 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $6.66 Million - $7.9 Million	-143,200 Reduced 8.45%	1,552,100 $81.4 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $2.96 Million - $3.67 Million	-64,700 Reduced 3.68%	1,695,300 $87.8 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $16.7 Million - $24.7 Million	403,300 Added 29.73%	1,760,000 $104 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $53.3 Million - $68.4 Million	1,356,700 New	1,356,700 $58.4 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.67 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.33 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.44 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account